scispace - formally typeset
H

Harvest F. Gu

Researcher at China Pharmaceutical University

Publications -  21
Citations -  424

Harvest F. Gu is an academic researcher from China Pharmaceutical University. The author has contributed to research in topics: Diabetes mellitus & Insulin resistance. The author has an hindex of 9, co-authored 21 publications receiving 241 citations.

Papers
More filters
Journal ArticleDOI

Genome-Wide Association Study of Diabetic Kidney Disease Highlights Biology Involved in Glomerular Basement Membrane Collagen.

Rany M. Salem, +97 more
TL;DR: In this paper, a large collection of type 1 diabetes cohorts with harmonized diabetic kidney disease phenotypes were assembled through collaboration with the Diabetes Nephropathy Collaborative Research Initiative, and 16 genome-wide significant risk loci were identified.
Journal ArticleDOI

Genetic and Epigenetic Studies in Diabetic Kidney Disease

TL;DR: Current information from genetic and epigenetic studies of DKD and ESRD in patients with diabetes, including the approaches of genome-wide association study (GWAS) or epigenome-wide associations study (EWAS) and candidate gene association analyses, are summarized.
Journal ArticleDOI

IL-21 Stimulates the expression and activation of cell cycle regulators and promotes cell proliferation in EBV-positive diffuse large B cell lymphoma

TL;DR: Analysis of a rare clinical sample of EBV-positive DLBCL, in combination with a NOD/SCID mouse xenograft model, confirmed the effect of IL-21 on the proliferation of EBv-positiveDLBCL cells and reconfirms the adverse effects of IL
Journal ArticleDOI

Chemical constituents, clinical efficacy and molecular mechanisms of the ethanol extract of Abelmoschus manihot flowers in treatment of kidney diseases.

TL;DR: The possible mechanism of Huangkui capsule treatment in kidney diseases may include reducing inflammation and anti‐oxidative stress, improving immune response, protecting renal tubular epithelial cells, ameliorating podocyte apoptosis, glomerulosclerosis and mesangial proliferation, as well as inhibiting renal fibrosis.
Journal ArticleDOI

Protective Effect of the HIF-1A Pro582Ser Polymorphism on Severe Diabetic Retinopathy

TL;DR: A protective effect of HIF-1A Pro582Ser against developing severe DR with a risk reduction of 95%, even when adjusting for known risk factors for DR such as diabetes duration, hyperglycemia, and hypertension.